About IntecPharma
IntecPharma is a company based in Jerusalem (Israel) founded in 2003. It operates as a B2B. IntecPharma has raised $5 million across 2 funding rounds from investors including Aspire Capital. IntecPharma operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
- Headquarter Jerusalem, Israel
- Stage Public
- SectorsHealthcare
- Website intecpharma.com
- Social X
- Total Equity Funding$5M (USD)
in 2 rounds
- Latest Funding Round$10M (USD), Post-IPO
Dec 2019
- Investors
Funding Insights of IntecPharma
IntecPharma has successfully raised a total of $5M across 2 strategic funding rounds. The most recent funding activity was a Post-IPO round of $10 million completed in December 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $5M
- Total Rounds 2
- Last Round Post-IPO — $10M
- First Round $5M
(Aug 2013)
- Investors Count 1
All 2 funding rounds of IntecPharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2019 | $10M | Post-IPO | – | – | |
| Aug 2013 | $5M | Private Equity Round | – | – | – |
1 investors in total: 1 institutional.
Investors in IntecPharma
IntecPharma has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Aspire Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | aspirecapital.com | - |
Investor details for IntecPharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of IntecPharma
5 people are tracked at IntecPharma (4 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Jeffrey A. Meckler | Vice Chairman & CEO | Leadership |
Walt A. Linscott | Chief Business Officer | Leadership |
Nadav Navon | Chief Operating Officer | Leadership |
Nir Sassi | Chief Financial Officer | Leadership |
Miriam Dagan | HR Manager | Team |
Complete people profiles for IntecPharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of IntecPharma
4 dated milestones of IntecPharma across 16 years, from founding to its latest funding, stage changes and deals.
- Founded IntecPharma is founded.
- Funding First funding round of $5.0M.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Post-IPO, of $10.0M.
Competitors of IntecPharma
IntecPharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| univercells.com | 2013 | Charleroi, Belgium | $150.64M | 87 | Biomanufacturing technologies are supplied for biopharma antibody and vaccine production. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform | |
| straumann.com | 1954 | Basel, Switzerland | – | – | Dental implants and regenerative dentistry products are developed. | |
| korrobio.com | 2018 | Cambridge, United States | $4M | 77 | RNA-editing technologies are provided for precision medicine applications. | |
| judges.uk.com | 2002 | London, United Kingdom | – | 622 | Acquisition and development of scientific instrument businesses is conducted. | |
| savarapharma.com | 2008 | Austin, United States | $67.82M | 37 | Therapeutics for rare respiratory diseases are developed by Savara Pharma. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. | |
| synthego.com | 2012 | Redwood, United States | $459.75M | – | CRISPR-engineered cell and gene therapies are developed for research applications. |
Detailed competitors of IntecPharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of IntecPharma
Websites that share an audience with IntecPharma (intecpharma.com).
Websites whose visitors overlap most with IntecPharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| aprecia.com | 99% | 2.6K | #5,861,353 | View details | |
| noven.com | 83% | 7.2K | #3,107,578 | View details |
Latest news on Intecpharma
Complete news archive for IntecPharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to IntecPharma
10 companies that operate in the same segment as IntecPharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about IntecPharma
IntecPharma was founded in 2003 and raised its 1st funding round 10 years after it was founded.
IntecPharma is headquartered in Jerusalem, Israel. It is registered at Jerusalem, Jerusalem District, Israel.
IntecPharma is a funded company, having raised a total of $5M across 2 funding rounds to date. The company's 1st funding round was a Private Equity Round of $5M, raised on Aug 2013.
IntecPharma, established in 2003 and currently in Dissolved stage, focuses on providing healthcare solutions, producing pharmaceutical products, drug delivery, and pharmacokinetics. Develops drug delivery technologies to enhance treatments for Parkinsons, insomnia, and ulcers. Adapting to market demands with innovation and client-focused strategies.
IntecPharma's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
IntecPharma has 1 investor. Key investors include Aspire Capital.